[Federal Register Volume 77, Number 63 (Monday, April 2, 2012)]
[Notices]
[Pages 19717-19718]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-7759]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application; 
Cerilliant Corporation

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on February 17, 2012, Cerilliant 
Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, 
made application by letter to the Drug Enforcement Administration (DEA) 
to be registered as a bulk manufacturer of the following basic classes 
of controlled substances:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
4-methyl-N-methylcathinone (1248)..........  I
3,4-methylenedioxypyrovalerone (7535)......  I
3,4-methylenedioxy-N-methylcathinone (7540)  I
Desomorphine (9055)........................  I
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to make reference standards which will be 
distributed to their customers.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODL), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than June 1, 2012.


[[Page 19718]]


     Dated: March 23, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2012-7759 Filed 3-30-12; 8:45 am]
BILLING CODE 4410-09-P